Foundation Medicine (@FoundationATCG) header
Foundation Medicine (@FoundationATCG) profile picture

Foundation Medicine is a precision medicine company transforming lives in cancer and other diseases. Community Guidelines: https://nitter.gq/t.co/XTZqTXqScf

Boston, MA
Joined January 2013
Photo by Foundation Medicine (@FoundationATCG)Photo by Foundation Medicine (@FoundationATCG)Photo by Foundation Medicine (@FoundationATCG)Photo by Foundation Medicine (@FoundationATCG)Photo by Foundation Medicine (@FoundationATCG)Photo by Foundation Medicine (@FoundationATCG)Photo by Foundation Medicine (@FoundationATCG)Photo by Foundation Medicine (@FoundationATCG)Photo by Foundation Medicine (@FoundationATCG)Photo by Foundation Medicine (@FoundationATCG)
Join us at #SABCS26 to explore our portfolio of high-quality tests and services for breast cancer, including FoundationOne®MRD for early-stage breast cancer. *FoundationOne MRD is performed by SAGA Diagnostics US, Inc. and has not been cleared or approved by the FDA.
1
2
4
233
Congratulations to @BloodCancerUtd on celebrating the 10-year anniversary of #BeatAML! We are honored to help play a part in supporting the trial by providing comprehensive genomic profiling to help match patients with AML to treatments quickly. Read more ⬇️
10 years of Beat AML®. Since 2016, 2,000+ patients have received genomic analysis and 720 patients enrolled across 17 clinical sub-studies. Findings have contributed to 65 peer-reviewed publications and abstracts. A decade of progress. More possibilities ahead. Read more: bcutd.org/4jnvgH9
3
3
179
📢 New Companion Diagnostic Approval – our blood-based comprehensive genomic profiling (CGP) test is now FDA-approved to identify patients with ER-positive, HER2-negative, ESR1-mutated advanced #BreastCancer. Read more: foundationmedicine.com/press…
3
5
239
This Cancer Biomarker Awareness Day, we’re helping to spread the word on #BiomarkerTesting and how it can be a crucial tool in a patient’s cancer care experience. #CBAD26 Hear more: youtu.be/fY2hgLMZfRI
3
3
199
Imagine detecting cancer recurrence before it can appear with standard imaging approaches. That’s now possible thanks to molecular residual disease (MRD) testing.
1
3
232
At Foundation Medicine, our rich history of scientific firsts in comprehensive genomic profiling has changed the course of precision medicine and forged a path for high-quality genomic testing in cancer.
1
4
3
195
Foundation Medicine will be at #AMP2026, booth 1701! Come learn about our latest offerings, including our MRD test for early-stage breast cancer, and how we can support pathology teams in delivering actionable genomic insights to help advance #PrecisionMedicine.
1
2
1
198
Heading to Seattle? Join our workshops on 11/11 or schedule a meeting to connect & explore how we can support your team: foundationmedicine.com/event… #AMP2026 *FoundationOne MRD is performed by SAGA Diagnostics US, Inc. and has not been cleared or approved by the FDA.
1
127
At Foundation Medicine, our rich history of scientific firsts in comprehensive genomic profiling has changed the course of precision medicine and forged a path for high-quality genomic testing in cancer.
1
2
8
258
Caregivers are an important source of strength, comfort & support for people living with cancer. Hear more from Casey, her perspectives on being a caregiver & how biomarker testing has helped play a role in her husband Keith’s treatment experience: youtu.be/Zc3qjxiLgOo
1
6
435
This #LungCancerAwarenessMonth, we recognize everyone impacted by lung cancer. We remain committed to advancing precision medicine to deepen our understanding of each patient’s cancer and help inform more personalized care.
3
243
Why does comprehensive genomic profiling (CGP) matter for advanced patient w/breast cancer? Tune in to this episode of “Genomics in Moments” to hear more about how CGP can help patients & their healthcare teams make informed treatment decisions in #BreastCancer care.
1
1
3
236
We are proud to be a @TheScientistLLC Top Innovations award recipient in Healthcare and Diagnostics for FoundationOne®MRD! This award honors cutting-edge technology shaping the future of life science, biotechnology and healthcare.
1
1
3
286
#Research at #ESMO26 assessed the real-world landscape of approved and emerging tumor-agnostic biomarkers across 385,420 solid tumor samples profiled with Foundation Medicine’s tissue-based comprehensive genomic profiling.
1
2
355